• Apac Pharmaceutical Market 2013 Deal Trends
    Mergers & Acquisition, Licensing and Collaboration & Partnerships are strategically analyzed to provide comprehensive understanding on areas such as structure and status of the deal vis a vis the overall corporate strategy. Complete report available @ http://www.reportsnreports.com/reports/267856-pharmasphere-asia-pacific-deal-trends-2004-2013...
    Premium 532 Words 2 Pages
  • Annual Report
    for becoming a Global Pharma Innovator. This annual report will explain in detail the accomplishments of the period covered by our First MTP and the basic strategies of our Second MTP in three sections: Expanding our business reach (Global); Fulfilling unmet medical needs (Pharma) by providing innovative...
    Premium 39028 Words 173 Pages
  • Indian Pharma Industry
    Paper Indian Pharma Industry and Corporate Social Responsibility Contents: Introduction: 4 Industry Trends: 4 Challenges: 4 Government Initiatives: 5 Pharma Export: 5 Corporate Social Responsibility-Meaning: 5 Key Players in Indian Pharmaceutical Industry: 6 Ranbaxy Laboratories Limited:...
    Premium 6011 Words 20 Pages
  • Jayesh
    RANBAXY LABORATORIES LIMITED Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies...
    Premium 1959 Words 7 Pages
  • Indian Pharma Industry
    bio-tech industry clocked a 17 percent growth with revenues of Rs.137 billion ($3 billion) in the 2009-10 financial year over the previous fiscal. Bio-pharma was the biggest contributor generating 60 percent of the industry's growth at Rs.8,829 crore, followed by bio-services at Rs.2,639 crore and bio-agri...
    Premium 4224 Words 14 Pages
  • Report on Osteoporosis Treatment
    higher-income group in the country will open a potential US$ 8 billion market for multinational companies selling costly drugs by 2015. Besides, the domestic pharma market is estimated to touch US$ 20 billion by 2015, making India a lucrative destination for clinical trials for global giants. Further estimates...
    Premium 7281 Words 25 Pages
  • Internationalisation Strategies of Indian Pharmaceutical Firms
    pharmaceuticals) and services (IT) and trading as well as high-technology sectors like semi-conductors. Some of the firms such as Infosys, Lenovo, Ranbaxy and Espat are now competing at a global level. Multinational enterprises from developing countries are a clear representation of a sustained increase...
    Premium 10851 Words 38 Pages
  • Pharmaceutical Sector Analysis - India
    Executive Summary ....................................................................................................................................... 5  PHARMA INDUSTRY OVERVIEW:‐ ................................................................................................................. 6  REGULATORY ASPECTS OF INDIA ...
    Premium 8741 Words 38 Pages
  • Indian Pharma
    Global Scenario * Therapeutic Market Segmentation Chapter 2: COUNTRY REVIEW 16 * Indian Pharmaceutical Industry * Industry Structure * Domestic Growth Drivers * Domestic Exports * Critical Success Factors * Pharmaceutical Regulatory Bodies In India Chapter 3:...
    Premium 25636 Words 79 Pages
  • Security Analysis of Pharmaceutical Industry
    Security analysis of pharmaceutical industry Shilpa medicare ltd, Ranbaxy, Dr Reedy [Pick the date] To Submitted- Prof. Raju Gundala ------------------------------------------------- By Submitted – Jitendra Singh ------------------------------------------------- Roll No. – 22, Section – C ...
    Premium 15095 Words 50 Pages
  • abc abc abc
    ‹› /138 Share Related More Fundamental analysis of pharma sector pptFundamental analysis of pharma sector ppt1480 viewsLike Performance analysis of working capital management of “pharmaceuticals industry”Performance analysis...
    Premium 22802 Words 65 Pages
  • Indian Pharmaceutical Industry
    Pharmaceutical Industry 1. Ranbaxy 2. Wockhardt 3. Glaxo Company GROWTH TONIC No of products Domestic turnover (Rs cr) 2,155.29 1,968.24 1,743.15 1,644.26 1,484.84 1,449.83 Market share (%) 5.38 4.91 4.35 4.11 3.71 3.62 Growth* (%) 4. Novartis 5. Cipla 6. Cadila Healthcare 7. Aurobindo Pharma 8. Dr Reddy¶s...
    Premium 12225 Words 41 Pages
  • Compensation Survey
    ............................ 9 COMPENSATION AND BENEFIT IN PERSPECTIVE ......................................................... 12 COMPENSATION STRUCTURES TODAY.............................................................................. 23 PERCEPTION OF CURRENT COMPENSATION & BENEFIT POLICIES.......
    Premium 10313 Words 49 Pages
  • Glaxo Smithkline
    the Organization 2 2.0 Market Share and Competition in the industry 3 2.1 Market Share 3 2.2 Portfolio 4 2.3 Competition 5 3.0 Industry Market Structure 7 4.0 Conclusion 8 5.0 References 9 1.0 Introduction 1.1 Objectives This assignment was prepared to understand and present an overview...
    Premium 1553 Words 7 Pages
  • Indian Healthcare Industry
    Index S.No. Table of Contents – – – – – – Major Risk to Indian Pharma Companies Global Pharma Market Pharmerging Economies Deals in Pharma Industry Major Players Profile of Major Players Industry Overview Risk Cover Structure Challenges in Health Insurance Major Players Page No. 55-56 57 58...
    Premium 15925 Words 80 Pages
  • Swot Analysis in Pharmaceutical Industry
    opportunity for Indian pharma companies. Around 70% of the total population of India is residing in rural areas. 13. Growing awareness for health and increasing spending on health Threats: 1. There are certain concerns over the patent regime regarding its current structure. It might be possible...
    Premium 5112 Words 20 Pages
  • Role of Pharmaceutical Industry in India
    as seven out of the top ten players are Indian. The formulation market in India is quite concentrated. The top five formulations companies, Cipla, Ranbaxy, GlaxoSmithKline, Cadila Healthcare, and Piramal Healthcare, accounted for about 22.3 per cent of the domestic formulation market in 2007-08. The market...
    Premium 3777 Words 12 Pages
  • Indian Pharma Industry
    Research..................................................22 ANALYSIS OF KEY PLAYERS OF THE SECTOR:............................................24 RANBAXY LABORATORIES LIMITED...........................................................24 CIPLA.............................................................
    Premium 6645 Words 23 Pages
  • Report on Ranbaxy
    Ten Years at a Glance....................................62 Auditors' Report.............................................63 Financial Statements of Ranbaxy Standalone .....................................................66 Consolidated Indian GAAP.........................111 Sales Rs. Million Global...
    Premium 55231 Words 190 Pages
  • Pfizer
    MARKETING STRATEGIES BY PFIZER AND RANBAXY A Seminar Paper Presented to Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s Narsee Monjee Institute of Management Studies (NMIMS) By DHARMENDER Roll No -07 (BATCH-B) Under the Mentorship of ...
    Premium 4149 Words 19 Pages